RNA genetics of breast cancer: maspin as paradigm.
Sager
R
R
Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Sheng
S
S
Anisowicz
A
A
Sotiropoulou
G
G
Zou
Z
Z
Stenman
G
G
Swisshelm
K
K
Chen
Z
Z
Hendrix
M J
MJ
Pemberton
P
P
D000595:Amino Acid Sequence; D000818:Animals; D000906:Antibodies; D001943:Breast Neoplasms / Q000235:genetics*; D002874:Chromosome Mapping; D015536:Down-Regulation; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D016147:Genes, Tumor Suppressor; D006801:Humans; D008969:Molecular Sequence Data; D014176:Protein Biosynthesis; D011506:Proteins / Q000235:genetics* / Q000276:immunology; D012333:RNA, Messenger / Q000235:genetics*; D012334:RNA, Neoplasm / Q000235:genetics*; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics; D017386:Sequence Homology, Amino Acid; D015842:Serine Proteinase Inhibitors / Q000235:genetics; D015843:Serpins / Q000096:biosynthesis / Q000235:genetics* / Q000276:immunology; D014162:Transfection; D014407:Tumor Cells, Cultured
D000906:Antibodies; D011506:Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D011994:Recombinant Proteins; C085344:SERPIN-B5; D015842:Serine Proteinase Inhibitors; D015843:Serpins